CD30-Positive Peripheral T-Cell Lymphoma
1 clinical trials · Condition
◉ Watch CD30-Positive Peripheral T-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain (NCT07624838) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2026-02-15 |
Track CD30-Positive Peripheral T-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.